Osteoporosis Drugs Market : Rising prevalence of osteoporosis and aging population boosts the growth of the global industry
Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=133
As per the analysis done by TMR, by drug class the bisphosphonates segment is the fastest growing segment in the osteoporosis drugs market during the forecast period. Geographically, North America is the leading the global osteoporosis drugs market, mainly due to increased number suffering from osteoporosis. Technological advancements and increasing awareness about the disease have also grown in this region. Increasing population in the Asia Pacific will also boost the demand for osteoporosis drugs market in the forecast period.
Demand for Osteoporosis Drugs High Among Geriatric Population
Osteoporosis develops due to increasing pores in the bones. As the density in the bones increases. It makes the bones weaker and breakable. Thus, increasing the risk of fractures, mainly in wrist, hip, and spinal vertebrae. The development of bone tissues continues until late 30’s and then starts reducing rapidly. If it reduces rapidly, it results in osteoporosis. Osteoporosis is largely seen among females as compared to males, mainly after menopause that decreasing estrogen in the body.
Major factors surging the demand for osteoporosis drugs is the huge population suffering from this disease. According to the International Osteoporosis Foundation (IOF), the number of women suffering from osteoporosis has crossed more than billion. As a result, globally the demand for osteoporosis drugs is increasing rapidly at an alarming rate. In addition, with the development of new drugs classes that are generic in nature and reduces the side effects, as well as it also overcomes the threat of chronic drugs will also grow the global market for osteoporosis drugs.
Enquiry for Discount on this Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=133
Changing Living Patterns May Increase Osteoporosis among Men
A study conducted by National Institutes of Health Osteoporosis and Related Bone Diseases, discloses that the changing living patterns and increasing consumption of alcohol, smoking, and sedentary lifestyle will raise the risk of osteoporosis in males. Thus, creating urgency to curb this disease and eventually increasing the demand for osteoporosis drugs market. The availability of a huge variety of pipeline drugs waiting for their approval in clinical trials will also boost the osteoporosis market. Abaloparatide, Romosozumab, ZP-PTH, Blosozumab, and ZP-034 are drugs yet to make their presence and curb the osteoporosis in the market. Furthermore, constant research and development by health organizations and companies to improvise newer techniques and develop alternative treatments is expected to grow the market in future. Additionally, increasing investments through various organizations is predicted to boost the global osteoporosis drugs market.
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Osteoporosis Drugs Market : Rising prevalence of osteoporosis and aging population boosts the growth of the global industry here
News-ID: 1164001 • Views: 474
More Releases from Transparency Market Research
Oligonucleotide Therapeutics Market Size, Status, Scope and Growth Prospects 202 …
Global Oligonucleotide Therapeutics Market: Overview Oligonucleotides refer to short chain DNA or RNA that are generally made by using automated synthesizers. In addition, purification of oligonucleotide is accomplished by anion exchange chromatography and it is followed by the techniques of freezing and desalting. In addition, synthesis of siRNA duplex oligonucleotide is done through an annealing step in which two purified strands of oligonucleotide are brought closer together in an equimolar ratio.
Seasonal Affective Disorder Therapeutics Market Size, Status, Scope and Growth P …
Global Seasonal Affective Disorder Therapeutics Market: Overview From 2020 to 2030, the global seasonal affective disorder is set to witness new profitable avenues. It is set to chart growth at a sturdy rate, compounded annually, with massive contributions coming from the North American region. On the other hand, Asia Pacific is anticipated to grow at an impressive CAGR. Transparency Market Research notes that various factors are contributing towards the projected growth. These
Esthetic Lasers and Energy Devices Market set to witness surge in demand over th …
In the past few years, the cosmetic industry has found new bioactive and high potency ingredients, which offer noticeable skin benefits to consumers. Various technological advancements in the esthetic industry, increase in disposable income, surge in awareness about skin rejuvenation & appearance are the major factors driving demand for esthetic procedures in developed as well as developing markets. The trend of adoption of innovative and advanced surgical devices in the
Image Guided Surgery Devices Market Analysis and Research Report by Experts 2025
The global image guided surgery devices market is directly reliant on the development of healthcare across various regional longitudes of the world. As the healthcare industry make rapid advancements across a number of its sub-domains, the market for global image guided surgery devices would see the entry of new players into the market. The competition is expected to intensify in the coming years and wreak the need for proper strategizing
More Releases for Osteoporosis
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.
Bone Densitometry Scan for Osteoporosis & Osteopenia
Global Bone Densitometers Market: Snapshot Of late, the global bone densitometers market has been registering a phenomenal increase in its size and valuation. The significant rise in the pool of patients suffering from arthritis and vitamin D deficiency, supported by the surge in the geriatric population across the world, have influenced this market substantially. The increasing prevalence of osteoporosis in post-menopausal women is also contributing considerably to the growth of
2022 Osteoporosis Drugs Market Analysis & Forecast
Global Osteoporosis Drugs Market Information, by drug class (Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH) and Others), by route of administration (oral, injectable and others) and by gender (male and female) - Forecast to 2022 The Global Osteoporosis Market to reach 14,300 million by 2022, growing with a CAGR of 4.7%. Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone
Datamonitor Healthcare Osteoporosis KOL Interviews
ReportsWorldwide has announced the addition of a new report title Datamonitor Healthcare Osteoporosis KOL Interviews to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/datamonitor-healthcare-osteoporosis-kol-interviews February 03, 2017 Datamonitor Healthcare interviewed an endocrinologist based in the US and a rheumatologist based in the UK to gauge their views on current treatment options, late stage clinical candidates, treatment challenges
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related
Rising Prevalence of Osteoporosis and Aging Population Boosts the Growth of Oste …
Osteoporosis is a chronic and life-threatening disease, in which microstructure of bones is altered due to reduction in bone mass and bone density. This condition leads to increased bone fragility and threat of bone cracks and fractures. Thus, osteoporosis is considered life threatening due to severe injury and associated pain. The osteoporosis drugs market report studies the current scenario as well as the future market potential for osteoporosis drugs globally.